Pfizer scrambles to fill void after Teva stops making chemo drug often given to children

Pfizer is playing a new role in the dramas that often surround drug shortages. While manufacturing issues at its Hospira unit have sometimes been responsible for hospital drug shortages, Pfizer is now trying to fill a serious shortfall after Teva discontinued production of a chemo drug used to cure children of serious cancers.